Behavior of Troponin as a Biomarker of Myocardial Injury in Patients with End-Stage Kidney Disease Hospitalized for Sepsis
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUNDTroponin is the preferred biomarker for diagnosing acute coronary syndrome.However, in asymptomatic patients with end-stage kidney disease (ESKD), baseline elevations of troponin are common.High-sensitivity cardiac troponin I (hs-cTnI) exceeds the 99 th percentile in approximately 38% of these patients, whereas high-sensitivity cardiac troponin T is elevated in about 68%.This higher prevalence of baseline troponin elevation makes interpretation difficult during acute illness in these patients.Its prognostic significance is still uncertain in patients receiving hemodialysis. AIMTo evaluate serial plasma hs-cTnI levels and their association with short-term mortality among ESKD patients hospitalized with sepsis.
Source: World Journal of Nephrology
DOI: 10.5527/wjn.127146
Institution: Sindh Institute of Urology and Transplantation
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7236445782
